<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lin TY</submitter><funding>Ministry of Science and Technology, Taiwan</funding><funding>Taipei Tzu Chi Hospital</funding><pagination>20</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7930281</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>7(1)</volume><pubmed_abstract>Little is known about the relationship between gut dysbiosis, inflammation, and adverse outcomes in patients with chronic kidney disease. We examined the association of microbial diversity with all-cause mortality in hemodialysis patients. The gut microbiota was assessed by 16S ribosomal RNA gene sequencing. During a median follow-up of 2.1 years, the adjusted risk of death among patients with higher diversity (above median) was 74% lower than that among patients with lower diversity (below median). We then compared the microbial composition between nonsurvivors and survivors in a matched case-control study. We observed significantly lower microbial diversity and higher proinflammatory cytokines among nonsurvivors than survivors. Specifically, the relative abundance of Succinivibrio and An</pubmed_abstract><journal>NPJ biofilms and microbiomes</journal><pubmed_title>Gut dysbiosis and mortality in hemodialysis patients.</pubmed_title><pmcid>PMC7930281</pmcid><funding_grant_id>MOST 108-2314-B-303-004-MY3</funding_grant_id><funding_grant_id>MOST 105-2314-B-303-014-MY3</funding_grant_id><funding_grant_id>MOST 108-2314-B-303-002-MY3</funding_grant_id><funding_grant_id>TCAS-108-02</funding_grant_id><funding_grant_id>MOST 107-2314-B-303-021</funding_grant_id><pubmed_authors>Lin YT</pubmed_authors><pubmed_authors>Wu PH</pubmed_authors><pubmed_authors>Lin TY</pubmed_authors><pubmed_authors>Hung SC</pubmed_authors></additional><is_claimable>false</is_claimable><name>Gut dysbiosis and mortality in hemodialysis patients.</name><description>Little is known about the relationship between gut dysbiosis, inflammation, and adverse outcomes in patients with chronic kidney disease. We examined the association of microbial diversity with all-cause mortality in hemodialysis patients. The gut microbiota was assessed by 16S ribosomal RNA gene sequencing. During a median follow-up of 2.1 years, the adjusted risk of death among patients with higher diversity (above median) was 74% lower than that among patients with lower diversity (below median). We then compared the microbial composition between nonsurvivors and survivors in a matched case-control study. We observed significantly lower microbial diversity and higher proinflammatory cytokines among nonsurvivors than survivors. Specifically, the relative abundance of Succinivibrio and An</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Mar</publication><modification>2025-04-22T08:20:45.232Z</modification><creation>2025-04-05T22:30:16.556Z</creation></dates><accession>S-EPMC7930281</accession><cross_references><pubmed>33658514</pubmed><doi>10.1038/s41522-021-00191-x</doi></cross_references></HashMap>